Table 6 shows risk estimates for the GFCT risk stratification in relation to prostate cancer of Grade Group ≥ 1 (any cancer) and Grade Group ≥ 3 (clinically significant cancer) and the previously defined Riskman score based on age, PSA, and PSAft%. The gene discussed is KLK3; the disease is prostate cancer.